Yet another study found that erastin-treated HER2-positive breast cancer cells presented significantly high expression levels of circ-COL1A2, circ-SC5D, circ-MSH2, circ-ACRBP, and circ-DTL compared with untreated cells (Wang et al., 2022a). The gene discussed is ERBB2; the disease is breast cancer.